CVS Health Earns Recognition for AI-Driven Innovations in Patient Care

CVS Health® (NYSE: CVS), a leading player in the health solutions sector, announced today that it has been awarded the prestigious 2026 AI Impact Award by Newsweek in the AI Health Care category, specifically for Best Outcomes – Patient Care. This accolade recognizes CVS Health's innovative AI-Driven Prescription Interpretation and Instruction Standardization technology, which integrates artificial intelligence into pharmacy dispensing workflows to enhance medication safety and patient care across its expansive national pharmacy network.

"This recognition reflects our commitment to applying AI in ways that ultimately free up our clinicians' time to better serve patients," stated Tony Ambrozie, Senior Vice President and Chief Digital and Technology Officer at CVS Health. He emphasized that embedding intelligent automation into pharmacy workflows allows pharmacists and technicians to concentrate on their core competencies—providing expert clinical support to patients. Ambrozie added, "This is what responsible, patient-centric AI looks like in practice."

As the U.S. healthcare system grapples with the complexities of electronic prescriptions, pharmacies often encounter intricate directions for use. Traditionally, these instructions necessitated manual transcription by pharmacy teams, which not only increased administrative burdens but also limited the time clinicians could devote to direct patient support.

CVS Health has tackled this challenge by deploying trained open-source large language models (LLMs) to interpret prescriber directions. These models effectively parse clinical terminology, conditional dosing logic, and contextual nuances that legacy rules-based systems could not manage. Additionally, AI-driven logic assesses frequency, quantity, and duration fields to calculate precise dosage supply—streamlining one of the most labor-intensive steps in the prescription processing workflow.

The implementation of this AI technology has yielded significant, measurable results in both retail and specialty pharmacy settings:

In retail pharmacy environments, automating the repetitive task of prescription interpretation has accelerated prescription fulfillment, minimizing delays at the point of care. The operational efficiencies gained have been redirected to expand clinical support capabilities, allowing pharmacists to devote more time to patient interaction.

In specialty pharmacy, where patients frequently manage chronic, rare, or life-threatening conditions, the AI-driven tool has proven invaluable. It has expedited the onboarding process for new patients and facilitated faster prescription fulfillment, enabling patients to commence therapy sooner.

Throughout the development of this technology, CVS Health prioritized patient safety and responsible AI deployment. The performance of AI models is continuously evaluated against stringent pharmacy accuracy benchmarks, and human-in-the-loop safeguards ensure that pharmacists maintain the final clinical authority in decision-making processes.

CVS Health stands as a prominent health solutions company dedicated to simplifying healthcare for individuals, families, and communities. As of March 31, 2026, CVS Health operates approximately 9,000 retail pharmacy locations and more than 1,000 walk-in and primary care medical clinics. The company also boasts a leading pharmacy benefits manager serving around 88 million plan members and provides a diverse range of health insurance products and related services to over 37 million people. CVS Health's integrated model focuses on personalized, technology-driven services that enhance access to quality care, deliver improved health outcomes, and reduce overall costs.

For more information regarding CVS Health's technology and innovation initiatives, interested parties can visit CVSHealth.com.

This recognition by Newsweek underscores CVS Health's ongoing commitment to leveraging technology to improve patient care and safety, solidifying its position as a leader in the healthcare industry.